These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 21959557)

  • 1. Evaluation of the efficacy and safety of Griflow(®) Dual, a pre-set two-flow infusion device for intravenous immunoglobulin (Flebogamma(®) 5%) administration.
    Sánchez A; Álvarez M; Bustillo MA; García MC; Muñoz M; Pacios C; Pizarroso L; Rubio MI; Rodríguez N
    J Vasc Access; 2012; 13(1):101-7. PubMed ID: 21959557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flebogamma(®) 5 % DIF Intravenous Immunoglobulin for Replacement Therapy in Children with Primary Immunodeficiency Diseases.
    Ballow M; Pinciaro PJ; Craig T; Kleiner G; Moy J; Ochs HD; Sleasman J; Smits W
    J Clin Immunol; 2016 Aug; 36(6):583-9. PubMed ID: 27279130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro measurement of flow rate variability in neonatal IV therapy with and without the use of check valves.
    van der Eijk AC; van der Plas AJ; van der Palen CJ; Dankelman J; Smit BJ
    J Neonatal Perinatal Med; 2014; 7(1):55-64. PubMed ID: 24815706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medication and volume delivery by gravity-driven micro-drip intravenous infusion: potential variations during "wide-open" flow.
    Pierce ET; Kumar V; Zheng H; Peterfreund RA
    Anesth Analg; 2013 Mar; 116(3):614-8. PubMed ID: 23400996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An open, prospective trial investigating the pharmacokinetics and safety, and the tolerability of escalating infusion rates of a 10% human normal immunoglobulin for intravenous infusion (IVIg), BT090, in patients with primary immunodeficiency disease.
    Kriván G; Königs Ch; Bernatowska E; Salama A; Wartenberg-Demand A; Sonnenburg C; Linde R
    Vox Sang; 2015 Oct; 109(3):248-56. PubMed ID: 25953213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of drug delivery disturbances during continuous intravenous infusion: an in vitro study on a new multi-lumen infusion access device.
    Foinard A; Décaudin B; Barthélémy C; Debaene B; Odou P
    Ann Fr Anesth Reanim; 2013 Sep; 32(9):e107-12. PubMed ID: 23958179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel Pump Control Technology Accelerates Drug Delivery Onset in a Model of Pediatric Drug Infusion.
    Parker MJ; Lovich MA; Tsao AC; Deng H; Houle T; Peterfreund RA
    Anesth Analg; 2017 Apr; 124(4):1129-1134. PubMed ID: 28181934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and in vitro evaluation of a flow-adjustable elastic drug infusion pump.
    Choi SW; Kang SM; Kim HY; Nam KW
    Proc Inst Mech Eng H; 2011 Nov; 225(11):1070-7. PubMed ID: 22292205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surveillance study on the tolerability and safety of Flebogamma
    Alsina L; Mohr A; Montañés M; Oliver X; Martín E; Pons J; Drewe E; Papke J; Günther G; Chee R; Gompels M;
    Pharmacol Res Perspect; 2017 Oct; 5(5):. PubMed ID: 28971614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Syringe Pump Performance Maintained with IV Filter Use During Low Flow Rate Delivery for Pediatric Patients.
    Chau DF; Vasilopoulos T; Schoepf M; Zhang C; Fahy BG
    Anesth Analg; 2016 Sep; 123(3):705-14. PubMed ID: 27074895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flow rate, syringe size and architecture are critical to start-up performance of syringe pumps.
    Neff SB; Neff TA; Gerber S; Weiss MM
    Eur J Anaesthesiol; 2007 Jul; 24(7):602-8. PubMed ID: 17261217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time-delay when updating infusion rates in the Graseby 3400 pump results in reduced drug delivery.
    Sarraf E; Mandel JE
    Anesth Analg; 2014 Jan; 118(1):145-50. PubMed ID: 24356164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a novel flow-controlled syringe infusion pump for precise and continuous drug delivery at low flow rates: a laboratory study.
    Batliner M; Weiss M; Dual SA; Grass B; Meboldt M; Schmid Daners M
    Anaesthesia; 2019 Nov; 74(11):1425-1431. PubMed ID: 31373391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An in vitro evaluation of infusion methods using a syringe pump to improve noradrenaline administration.
    Genay S; Décaudin B; Scoccia S; Barthélémy C; Debaene B; Lebuffe G; Odou P
    Acta Anaesthesiol Scand; 2015 Feb; 59(2):197-204. PubMed ID: 25476454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety monitoring of the intravenous immunoglobulin preparation Intratect® in primary and secondary immunodeficiencies: a prospective non-interventional study.
    Bauhofer A; Dietrich RL; Schmeidl R
    Int J Clin Pharmacol Ther; 2015 Jan; 53(1):21-31. PubMed ID: 25345431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy, pharmacokinetics, safety, and tolerability of Flebogamma 10% DIF, a high-purity human intravenous immunoglobulin, in primary immunodeficiency.
    Berger M; Pinciaro PJ; Althaus A; Ballow M; Chouksey A; Moy J; Ochs H; Stein M
    J Clin Immunol; 2010 Mar; 30(2):321-9. PubMed ID: 19997861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety, efficacy, and pharmacokinetics of Flebogamma 5% [immune globulin intravenous (human)] for replacement therapy in primary immunodeficiency diseases.
    Berger M; Pinciaro PJ;
    J Clin Immunol; 2004 Jul; 24(4):389-96. PubMed ID: 15163895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infusion pump delivers over-dosage of propofol as a result of missing syringe support.
    Koch C; Hollister C; Breen PH
    Anesth Analg; 2006 Apr; 102(4):1154-6. PubMed ID: 16551915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An analysis of drug delivery dynamics via a pediatric central venous infusion system: quantification of delays in achieving intended doses.
    Bartels K; Moss DR; Peterfreund RA
    Anesth Analg; 2009 Oct; 109(4):1156-61. PubMed ID: 19762743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary Intravenous Set Consumption Across 3 Branded Infusion Pumps.
    Hedlund N; Sarangpur S; Kayler S; OʼBrien K; Beer I
    J Infus Nurs; 2017; 40(4):206-214. PubMed ID: 28682999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.